ArticleCancers2025

Discordance Between Radiological and Pathological Responses to Pembrolizumab in Mismatch Repair-Deficient Metastatic Colorectal Cancer: Implications for Precision Oncology.

Yoshifumi Shimada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.